Skip to main content

Featured

Ukrainian Strike Hits Major Industrial Facility Deep Inside Russia

  In this photo provided by Ukraine's 65th Mechanized Brigade press service, a local passes by a destroyed apartment building following an Russian air strike in the town of Komyshuvakha in the Zaporizhzhia region of Ukraine, Friday, Feb. 20, 2026.  A long‑range Ukrainian strike has reportedly targeted a significant industrial site far inside Russian territory, marking one of Kyiv’s deepest attacks since the start of the full‑scale invasion. Early reports from regional officials in Russia indicate that the strike caused a fire at the facility, which is believed to play a role in supporting Moscow’s military production. Ukrainian officials have not publicly claimed responsibility, consistent with their policy of strategic ambiguity regarding operations beyond their borders. However, the attack aligns with Kyiv’s stated goal of disrupting Russia’s defense‑industrial capacity, especially as the war enters another year with both sides relying heavily on long‑range drones and prec...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment